The past decade has seen a rich interaction between the fields of neurology and immunology. This has provided further insight into the mechanisms of immunologically mediated neurological diseases and given rise to new therapies for many neuroimmunological diseases, including multiple sclerosis (MS). To understand and effectively employ these emerging neuroimmunologically based therapies, a solid grasp of immunology is required. Here we provide an overview of the major components of the immune system and highlight important advances in the field of neuroimmunology, with a focus on relevant disease processes and treatment strategies.

Immune System

The function of the immune system is to protect the organism against infectious agents and prevent reinfection by maintaining immunological memory. Additionally, the immune system performs tumor surveillance, promotes healing, and prevents damage mediated by dying cells.

The immune system normally does not react to self-antigens, a state known as tolerance , except in the setting of autoimmune disease. An overactive immune system may mediate ongoing immune-mediated damage, so a delicate balance must be maintained between the protective effects of the immune system and potential deleterious effects.

The normal functions of the immune system and the disorders resulting from its dysfunction are listed in Box 49.1 .

BOX 49.1
Normal Functions and Disorders of the Immune System

Normal Functions

  • Immunity against microorganisms and pathogens

  • Wound healing

  • Tumor surveillance

Disorders Resulting From Immune System Dysfunction

  • Autoimmunity

  • Immune-mediated disorders

  • Bystander damage

  • Graft rejection

Adaptive and Innate Immunity

The immune system has two functional divisions: the innate immune system and the adaptive immune system. The innate immune system acts nonspecifically as the body’s first line of defense against pathogens. However, this type of response, if perpetuated, would result in unwanted nonspecific damage to the host. Therefore a secondary, antigen-specific response develops and leads the attack. This is mediated by T cells and B cells, which are equipped with antigen-specific receptors. The effector cells release mediators and trigger other components of the immune system to eliminate the target. Subpopulations of T and B cells develop and maintain immunological memory, which facilitates a more rapid response in the case of recurrent infection.

The innate immune system consists of the following components:

  • 1.

    Skin—The exterior surface of the body, primarily the skin, is the body’s primary defense against foreign pathogens. Many inflammatory cells and antigen-presenting cells (APCs) line the epidermis and serve as the first line of defense.

  • 2.

    Phagocytes are cells capable of phagocytosing foreign pathogens. They include polymorphonuclear cells, monocytes, and macrophages. These cells are present in the blood as well as in organs. Phagocytes recognize cell components or pathogen-associated molecular patterns (PAMPs) of a variety of microorganisms through families of pattern recognition receptors (PRRs) expressed on their cell surface. PRRs allow phagocytes to attach nonspecifically and phagocytose pathogens, which are then killed via intracellular lysosomes. Families of PRRs include the Toll-like receptors (TLRs) and the nucleotide-binding oligomerization domain (NOD) receptors.

  • 3.

    Natural killer (NK) cells—NK cells recognize cell surface molecules on virally infected or tumor cells. They subsequently bind to the infected cells and kill them via cell-mediated cytotoxicity.

  • 4.

    Acute-phase proteins—C-reactive protein is a model acute-phase protein whose concentration increases in response to infection. C-reactive protein binds to cell surface molecules on a variety of bacteria and fungi and acts as an opsonin, essentially increasing recognition of pathogens by phagocytic cells.

  • 5.

    Complement system—The complement system is a cascade of serum proteins whose overall function is to enhance and mediate inflammation. The complement system has the intrinsic ability to lyse the cell membranes of many cells including bacteria. It functions in concert with components of both the innate and adaptive immune systems and can also act as an opsonin, facilitating phagocytosis. The complement cascade can be directly activated by certain microorganisms through the alternative pathway, or it can be activated by particular antibody subtypes through the classical pathway.

The adaptive immune response consists of the following components:

  • 1.

    Antibodies—Otherwise known as immunoglobulins (Igs), antibodies are able to specifically recognize a variety of free antigens. Igs are produced by B cells and are present on their cell surface. In addition, Igs are secreted in large amounts in the serum. Antibodies recognize specific microbial and other antigens through their antigen-binding sites and bind phagocytes via their Fc receptors, thereby facilitating antigen removal. Some subclasses of Ig are capable of activating complement via their Fc portion, thereby lysing their targets.

  • 2.

    B cells—The primary function of B cells is to produce antibody. Antigen binding to B cells stimulates proliferation and maturation of that particular B cell, with subsequent enhancement of antigen-specific antibody production, resulting in the development of antibody-secreting plasma cells. Most B cells express class II major histocompatibility complex (MHC) antigens and have the ability to function as APCs.

  • 3.

    T cells, or thymus-derived cells, have the ability to recognize specific antigens via their T-cell receptors (TCRs). T cells may be classified into two main groups: T-helper (T H ) cells expressing CD4 antigen on their cell surface, and T-cytotoxic (T C ) cells expressing CD8 on their surface. CD4 T cells recognize antigen presented in association with MHC class II on the surface of APCs. CD4 T cells help to promote B-cell maturation and antibody production and produce factors called cytokines to enhance the innate or nonspecific immune response. CD8 T cells recognize antigen in association with MHC class I antigen on the surface of most cells and play an important role in eliminating virus-infected cells. Cytotoxic T cells are capable of damaging target cells via the release of degrading enzymes and cytokines. Responses in which the T cell plays a major role are termed cell-mediated immunity (CMI). T-cell–macrophage interactions often lead to delayed reactions, termed delayed-type hypersensitivity (DTH).

  • 4.

    APCs are required to present antigen to T cells. They are found primarily in the skin, lymph nodes, spleen, and thymus. Unlike B cells that can recognize free antigen, T cells are only capable of recognizing antigen in the context of self-MHC molecules. APCs process antigen intracellularly and present antigen peptide in the groove of their MHC class II molecules. The primary APCs are macrophages, monocytes, dendritic cells, and Langerhans cells.

Principal Components of the Immune System

Cells of the immune system arise from the pluripotent stem cells in the bone marrow and diverge into the lymphoid or myeloid lineages. The myeloid lineage primarily contains cells with phagocytic functions such as neutrophils, basophils, eosinophils, and macrophages. The lymphoid lineage consists of T cells, B cells, and NK cells.

Monocytes and Macrophages

Bone marrow–derived myeloid progenitor cells give rise to monocytes (mononuclear phagocytes of the reticuloendothelial system) that serve important immune functions. They constitute about 4% of the peripheral blood leukocytes and are morphologically identified by an abundant cytoplasm and a kidney-shaped nucleus. Their cytoplasm contains many enzymes, which are important for killing microorganisms and processing antigens. Monocytes differentiate into tissue-specific macrophages including Kupffer cells of the liver and brain microglia.

Natural Killer Cells

NK cells make up about 2.5% of peripheral blood lymphocytes and are synonymous with large granular lymphocytes because of their large intracytoplasmic azurophilic granules and high cytoplasm-to-nucleus ratio. NK cells are activated primarily in response to interferons and are involved in the elimination of virally infected host cells; they also play a role in tumor immunity. Unlike cytotoxic CD8 + T cells, NK cells lack immunological memory and have the ability to kill a wide variety of tumor and virus-infected cells without MHC restriction (see the discussion of the function of MHC genes) or activation. NK cells lack the cell surface markers present on B cells and T cells. NK1.1 + T cells are a subset of cells sharing characteristics of both NK cells and T cells. These cells express the α/β TCR and the NK1.1 receptor and secrete large amounts of interferon gamma (IFN-γ) or interleukin 4 (IL-4) in response to TCR stimulation.

T Lymphocytes

T cells originate from the thymus. Differentiation of T cells occurs in the thymus, and every T cell that leaves the thymus is conferred with a unique specificity for recognizing antigens. T cells that recognize self-antigens are generally either deleted or rendered tolerant within the thymus, a process called central tolerance .

T cells may be divided into two groups on the basis of expression of either the CD4 + or CD8 + marker. Functionally, CD4 + T cells are involved in DTH responses and also provide help for B-cell differentiation (and hence are termed helper T cells ). In contrast, CD8 + T cells are involved in class I restricted lysis of antigen-specific targets (and hence are termed cytotoxic T cells ). T cells with suppressor or regulatory activity can express either CD4 or CD8.

T-Cell Receptors

The TCR consists of two glycosylated polypeptide chains, alpha (α) and beta (β), of 45,000 and 40,000 Da molecular weight, respectively. This heterodimer of an α and β chain is linked by disulfide bonds. Amino acid sequences show that each chain consists of variable (V), joining (J), and constant (C) regions closely resembling Igs ( Fig. 49.1 ). There are about 10 2 TCR-variable genes grouped by homology into a small number of families, compared with 10 3 or greater for Igs (see later discussion). The principles governing generation of diversity in the TCR are very similar to those for Ig genes. T cells can only recognize short peptides that are associated with MHC molecules. In contrast, the Ig receptor can recognize peptides, whole proteins, nucleic acids, lipids, and small chemicals.

Fig. 49.1, Molecular and Genetic Organization of the T-Cell Receptor (TCR) and Immunoglobulin ( Ig ) Molecule.

T cells also express a variety of nonpolymorphic antigens on their surfaces. The most abundantly expressed is CD45, comprising 10% of lymphocyte membrane proteins. CD45 exists as a number of isoforms that differ in the molecular weight of their extracellular domains as a result of RNA splicing. These isoforms can be distinguished serologically. The low molecular weight (CD45RO) isoforms define activated, or memory, T-cell populations.

B Lymphocytes

B cells are the precursors of antibody-secreting cells. The cells develop in the bone marrow and during their ontogeny acquire Ig receptors that commit them to recognizing specific antigens for the rest of their lives. B cells normally express IgM on their cell surfaces but switch to other isotypes as a consequence of T-cell help, while maintaining antigen specificity (see later discussion). Following antigenic challenge, T lymphocytes assist (help) B cells directly (cognate interaction) or indirectly by secreting helper factors (noncognate interaction) to differentiate and form mature antibody-secreting plasma cells.

Immunoglobulins

Immunoglobulins are glycoproteins that are the secretory product of plasma cells. Their biochemical structure and genomic organization are shown in Fig. 49.1 . All Ig molecules share a number of common features. Each molecule consists of two identical polypeptide light chains (kappa [κ] or lambda [λ]) linked to two identical heavy chains. The light and heavy chains are stabilized by intrachain and interchain disulfide bonds. According to the biochemical nature of the heavy chain, Igs are divided into five main classes: IgM, IgD, IgG, IgA, and IgE. These may be further divided into subclasses depending on differences in the heavy chain.

Each heavy and light chain consists of variable and constant regions. The amino terminus is characterized by sequence variability in both the light and the heavy chain, and each variable heavy- and light-chain unit acts as the antigen-binding site (the Fab portion). The carboxy terminal of the heavy chain (also known as the Fc portion ) is involved in binding to host tissue and fixing complement. This part of the molecule is important for antibody-dependent, cell-mediated cytotoxicity by cells of the reticuloendothelial system and for complement-mediated cell lysis.

Classes of Igs differ in their ability to fix complement. In humans, IgM, IgG1, and IgG3 antibodies are capable of activating the complement cascade. Different Ig classes also differ in their transport properties and ability to bind to phagocytes. Fc binding to Fc receptors (FcRs) present on macrophages, dendritic cells, neutrophils, NK cells, and B cells initiates signaling within the cell only when the receptors are cross-linked by immune complexes containing more than one IgG molecule. Different FcRs mediate different cellular responses, some being predominantly stimulatory, while others are inhibitory.

Genetics of the Immune System

Antigen Receptor Gene Rearrangements

During B- and T-cell development, multiple gene rearrangements occur to form their respective antigen receptors, the Ig and the TCR. Diversity of the antigen receptors is due to diversity in their principal components, the V gene segment and the J gene segments. One of the many V gene segments is juxtaposed by chromosomal rearrangements with one of the J segments (and when present, with the diversity [D] segment) to form the complete variable region gene. Recombinational inaccuracies at the joining sites of the V, D, and J regions further increase the diversity of the antigen receptors.

C gene segments are present in all receptors. The V, D, J, and C gene segments along with the intervening noncoding gene segments between the J and C regions are initially transcribed into mature RNA. Through a process of RNA splicing, the noncoding gene segments are excised, and the V(D)JC messenger RNA (mRNA) is translated into protein. After binding antigen, B cells undergo somatic mutations that further increase the diversity and the affinity of antigen binding (affinity maturation). This phenomenon does not occur in T cells. During isotype switching in B cells, further rearrangements lead to recombination of the same variable region gene with new constant region genes (see Fig. 49.1 ).

Major Histocompatibility and Human Leukocyte Antigens

MHC gene products or the human leukocyte antigens (HLAs) serve to distinguish self from nonself. In addition, they serve the important function of presenting antigen to the appropriate cells. The MHC class I gene product contains an MHC-encoded α chain, and a smaller non-MHC-encoded β 2 -microglobulin chain. The MHC class II gene product consists of two polypeptide chains, α and β, which are noncovalently linked. Both class I and class II proteins are stabilized by intrachain disulfide bonds. Class I antigens are expressed on all nucleated cells, whereas class II antigens are constitutively expressed only on dendritic cells, macrophages, and B cells, and are expressed on a variety of activated cells including T cells, endothelial cells, and astrocytes.

In humans, class I molecules are HLA-A, B, and C, whereas the class II molecules are HLA-DP, DQ, and DR. Several alleles are recognized for each locus; thus the HLA-A locus has at least 20 alleles, and HLA-B has at least 40. The number of alleles for the D region appears to be as extensive as that for HLA-A, HLA-B, and HLA-C. In view of the extensive polymorphisms present, the chances of two unrelated individuals sharing identical HLA antigens are extremely low. The reason for the extensive diversity and evolutionary pressure that lead to this are not fully understood.

Class I antigens regulate the specificity of cytotoxic CD8 + T cells, which are responsible for killing cells bearing viral antigens or foreign transplantation antigens ( Fig. 49.2 ). The target cells share class I MHC genes with the cytotoxic cell. Thus the cytotoxic cell that is specific for a particular virus is capable of recognizing the antigenic determinants of the virus only in association with a particular MHC class I gene product. The function of class II MHC gene products appears to be to regulate the specificity of T-helper cells, which in turn regulate DTH and antibody response to foreign antigens. Similarly, an immunized T-cell population will recognize a foreign antigen only if it is presented on the surface of an APC that shares the same class II MHC antigen specificity as the immunized T-cell population. Thus the functional specificity of the T-cell population is restricted by the MHC molecules they recognize. CD8 + T cells (cytotoxic) and CD4 + T cells (helper) are referred to as MHC class I and MHC class II restricted T cells , respectively ( Fig. 49.3 ).

Fig. 49.2, The Phenomenon of Major Histocompatibility Complex (MHC) Restriction.

Fig. 49.3, Antigenic Recognition of Cytotoxic and Helper T Cells.

The analysis of the three-dimensional structure of the class I and class II molecules has confirmed the notion that these molecules are carriers of immunogenic peptides that are processed by APCs and presented on the cell surface ( Fig. 49.4 ). Both MHC class I and class II molecules share similarities in crystal structure that allow them to accept and retain immunogenic peptides in grooves, or pockets, and present them to T cells.

Fig. 49.4, Schematic Diagram of the Human Leukocyte Antigen (Hla) Complex in Humans, Located on Chromosome 6.

Organization of the Immune Response

Initiation of the Immune Response

Antigen Presentation

One of the crucial initial steps in the immune response is the presentation of encountered antigens to the immune system. Antigens are carried from their site of arrival in the periphery by way of lymphatics or blood vessels to the lymph nodes and spleen. There, antigens are then taken up by cells of the monocyte-macrophage lineage and by B cells, processed intracellularly, and presented not as whole molecules but as highly immunogenic peptides.

Accessory Molecules for T-Cell Activation

The interaction of MHC-peptide complex with T cells, although necessary, is insufficient for T-cell activation. Other classes of molecules are involved in T-cell antigen recognition, activation, intracellular signaling, adhesion, and trafficking of T cells to their target organs. The distinction between the functions of these classes of molecules is not absolute, and many may be involved in interactions between other cells of the immune system.

CD3

Molecules whose primary role is signaling include the CD3 molecule. The CD3 molecule is part of the TCR complex. Although the TCR interacts with the MHC-peptide complex on APCs, the signals for the subsequent enactment of T-cell activation and proliferation are delivered by the CD3 antigen. The cytoplasmic tail of the CD3 proteins contains one copy of a sequence motif important for signaling functions, called the immunoreceptor tyrosine-based activation motif (ITAM). Phosphorylation of the ITAM initiates intracellular signaling events. In experimental situations, anti-CD3 antibodies can nonspecifically activate these intracellular signals, producing activated T cells in the absence of antigen.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here